Fenneke Zwierenga

Fenneke Zwierenga is a researcher at the University of Groningen, specializing in molecular oncology with a focus on lung cancer mechanisms and targeted therapies. Her work addresses critical areas such as EGFR exon 20 mutations, ALK fusion genes, and resistance mechanisms in non-small cell lung cancer (NSCLC). She has contributed to studies on immunotherapy outcomes in malignant pleural mesothelioma and predictive modeling for treatment efficacy. Her research aligns with UN Sustainable Development Goals related to good health and well-being.

Key areas of research include drug resistance pathways, molecular biomarkers, and translational applications of computational models in oncology. Her studies frequently involve collaboration with Dutch medical institutions and utilize real-world clinical data for evidence-based insights.